Until recently, production of medical isotopes for NRG’s Belgian partner the Institut National des Radioéléments (IRE) were still produced using high-enriched uranium (HEU) because IRE could not fully process low-enriched uranium.
IRE has now partially converted its chemical process to LEU, meaning NRG – the world’s largest producer of medical isotopes – can take the final step and stop production at the HFR using HEU.
As part of the Treaty on the Non-Proliferation of Nuclear Weapons (NPT), which has been signed by 191 states, a consensus was reached on phasing out the use of HEU, which can be used to produce nuclear weapons.
Want to keep reading?
Register free and get full access to NucNet for 14 days. No card required.
- Daily news briefing on the global nuclear industry
- Weekly, monthly and topical newsletters
- 24/7 coverage during nuclear incidents and safety events
- Full searchable archive, 30,000+ articles since 1991
- SMR and AMR project database
- Analysis, Focus pieces and infographics
- NucNet Style Guide for nuclear reporters and communicators
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options